Medium and Long Term Outcome of Total Hip Arthroplasty Using Accolade TMZF Femoral Stem
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00951145
Verified April 2013 by Rothman Institute Orthopaedics. Recruitment status was: Active, not recruiting
This is a retrospective/prospective study evaluating the clinical and radiographic outcome of total hip arthroplasty (THA) performed using Accolade femoral stem in a consecutive group of patients. All patients eligible for inclusion will be identified. The investigators hypothesize that the outcome of THA performed using Accolade femoral stem is equal or superior to historical survivorship of THA using other types of collarless, proximally coated, tapered stems.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
Child, Adult, Senior
Sexes Eligible for Study:
Accepts Healthy Volunteers:
All patients undergoing THA prior to 1/1/2003 using Accolade femoral stem
All patients undergoing THA prior to 1/1/2003 using Accolade femoral stem.
Patients with hip fracture undergoing THA will also be included.
Patients willing and able to comply with follow-up requirements and self-evaluations.